Zenatech, INC Schedule 13D activist filings
Filed when an investor crosses five percent and intends to influence the company — the activist disclosure.
NASDAQ
ZENA
Zenatech, INCSCHEDULE: GG Mars Capital Acquires ZenaTech Stake
GG Mars Capital has acquired a significant stake in ZenaTech, Inc. by converting a line of credit and preferred shares into common stock.
NASDAQ
ZENA
Zenatech, INCStar Financial Corp. has acquired a significant stake in ZenaTech, Inc. by converting $4.432 million of outstanding debt into 2 million common shares.
NASDAQ
ZENA
Zenatech, INCDr. Shaun Passley and affiliated entities report a consolidated 86.5% beneficial ownership stake in ZenaTech, Inc. following recent equity grants and asset acquisitions.
NASDAQ
ZENA
Zenatech, INCStar Financial Corp has converted $4.43 million of debt into 2 million common shares of ZenaTech, Inc., increasing its beneficial ownership to 9.49%.
NASDAQ
ZENA
Zenatech, INCGG Mars Capital, Inc. has increased its beneficial ownership in ZenaTech, Inc. to approximately 8.298% through the conversion of a convertible line of credit.
NASDAQ
ZENA
Zenatech, INCGG Mars Capital, Inc. has increased its beneficial ownership in ZenaTech, Inc. to 6.51% after converting a portion of its convertible line of credit.
NASDAQ
ZENA
Zenatech, INCStar Financial Corp has increased its beneficial ownership in ZenaTech, Inc. to 7.1% through the conversion of convertible debt.
NASDAQ
ZENA
Zenatech, INCSCHEDULE 13D: GG Mars Capital Boosts ZenaTech Stake to 6.69%
GG Mars Capital, Inc. has increased its beneficial ownership in ZenaTech, Inc. to 6.694% of common stock through a debt-to-equity conversion.
NASDAQ
ZENA
Zenatech, INCGG Mars Capital, Inc. has converted a portion of its convertible line of credit into common stock, acquiring 8.1% beneficial ownership in ZenaTech, Inc. for investment purposes.
NASDAQ
ZENA
Zenatech, INCStar Financial Corporation has reported a significant beneficial ownership stake of approximately 7.1% in ZenaTech, Inc. following the conversion of a convertible line of credit into common shares.
NASDAQ
ZENA
Zenatech, INCSCHEDULE 13D: Dr. Shaun Passley and Affiliates Solidify Control of ZenaTech, Inc. with 89% Beneficial Ownership Post-Asset Acquisition
Dr. Shaun Passley, along with Epazz, Inc. and Ameritek Ventures, Inc., has significantly increased his beneficial ownership in ZenaTech, Inc. to 89% following the acquisition of assets from his controlled entities, approved by minority shareholders.
NASDAQ
ZENA
Zenatech, INCSCHEDULE 13D/A: Dr. Shaun Passley and Affiliates Disclose Significant ZenaTech, Inc. Ownership and Control
Dr. Shaun Passley, along with Epazz, Inc. and Ameritek Ventures, Inc., has filed an amended Schedule 13D, revealing a combined beneficial ownership of 48.0% of ZenaTech, Inc.'s common stock, primarily for investment purposes.
NASDAQ
ZENA
Zenatech, INCA recent Schedule 13D filing reveals Dr. Shaun Passley, along with Epazz, Inc. and Ameritek Ventures, Inc., collectively hold 48% beneficial ownership of ZenaTech, Inc.'s common stock.